Divalproex Sodium Delayed-Release Tablets — Class II drug recall D-0742-2026
Ongoing recall by Bionpharma Inc., reported 2026-07-29, distributed nationwide. Presence of Foreign Tablets/Capsules
| Recall number | D-0742-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bionpharma Inc., Princeton, NJ, United States |
| Recall initiated | 2026-06-26 |
| Classified | 2026-08-06 |
| Reported by FDA | 2026-07-29 |
| Distributed | Nationwide (US) |
| NDC | 69452-0433, 69452-0433-13, 69452-0433-20, 69452-0433-30, 69452-0434, 69452-0434-13, 69452-0434-20, 69452-0434-30, 69452-0435, 69452-0435-13, 69452-0435-20, 69452-0435-30 |
| Lot numbers | 704C003 |
| Expiration dates | 2028-12-31 |
Product
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0742-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.